Stocks and InvestingStocks and Investing
Thu, August 8, 2019
Wed, August 7, 2019
Tue, August 6, 2019
Mon, August 5, 2019
Fri, August 2, 2019
Thu, August 1, 2019

Paul Matteis Maintained (VRTX) at Strong Buy with Increased Target to $211 on, Aug 1st, 2019


Published on 2024-10-26 15:14:20 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $205 to $211 on, Aug 1st, 2019.

Paul, nor any peers, have made any analyst calls on VRTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30